These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 12847897

  • 1. [Microcirculatory disorders in systemic lupus erythematosus].
    Kozlova LK, Bagirova VV.
    Ter Arkh; 2003; 75(5):41-6. PubMed ID: 12847897
    [Abstract] [Full Text] [Related]

  • 2. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome].
    Kozlovskaia NL, Shilov EM, Meteleva NA, Varshavskiĭ VA, Miroshnichenko NG, Samokishina NA, Serova AG, Nesterova SG.
    Ter Arkh; 2006; 78(5):21-31. PubMed ID: 16889045
    [Abstract] [Full Text] [Related]

  • 3. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

  • 4. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
    Ermakova NA, Alekberova ZS, Reshetniak TM, Kalashnikova LA, Kosheleva NM.
    Vestn Oftalmol; 2005 Jun; 121(5):31-6. PubMed ID: 16274063
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Jiménez S, García-Criado MA, Tàssies D, Reverter JC, Cervera R, Gilabert MR, Zambón D, Ros E, Bru C, Font J.
    Rheumatology (Oxford); 2005 Jun; 44(6):756-61. PubMed ID: 15757967
    [Abstract] [Full Text] [Related]

  • 12. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [Abstract] [Full Text] [Related]

  • 13. [System of microcirculation, markers of vascular wall damage and systematicity of the process in rheumatic diseases].
    Shilkina NP, Butusova SV, Driazhenkova IV.
    Angiol Sosud Khir; 2014 Nov; 20(1):27-34. PubMed ID: 24722018
    [Abstract] [Full Text] [Related]

  • 14. [Characteristics of retinal vascular involvement in systemic lupus erythematosus].
    Ermakova NA, Alekberova ZS, Kosheleva NM, Reshetniak TN.
    Vestn Oftalmol; 2001 Nov; 117(2):21-4. PubMed ID: 11510158
    [Abstract] [Full Text] [Related]

  • 15. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
    Tarr T, Lakos G, Bhattoa HP, Szegedi G, Shoenfeld Y, Kiss E.
    Lupus; 2007 Nov; 16(5):324-8. PubMed ID: 17576733
    [Abstract] [Full Text] [Related]

  • 16. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
    Ruiz-Irastorza G, Egurbide MV, Ugalde J, Aguirre C.
    Arch Intern Med; 2004 Jan 12; 164(1):77-82. PubMed ID: 14718326
    [Abstract] [Full Text] [Related]

  • 17. Bullous systemic lupus erythematosus with antiphospholipid syndrome.
    Kacalak-Rzepka A, Zaluga E, Maleszka R, Królicki A, Klimowicz A.
    J Eur Acad Dermatol Venereol; 2004 Jul 12; 18(4):490-4. PubMed ID: 15196171
    [Abstract] [Full Text] [Related]

  • 18. [Nailfold capillary microscopy in patients with antiphospholipid syndrome].
    Candela M, Pansoni A, De Carolis ST, Pomponio G, Corvetta A, Gabrielli A, Danieli G.
    Recenti Prog Med; 1998 Sep 12; 89(9):444-9. PubMed ID: 9796374
    [Abstract] [Full Text] [Related]

  • 19. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun 12; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 20. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.
    Ann Rheum Dis; 2008 Mar 12; 67(3):395-401. PubMed ID: 17644539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.